Table 5.
Antibiotic (number of samples) | Disk content (µg) | Resistance status (R+I) | Susceptibility status (S) |
---|---|---|---|
Cephalexin (n = 14) | 30 | 100 | 0 |
Clindamycin (n = 2) | 2 | 100 | 0 |
Tetracycline (n = 4) | 30 | 100 | 0 |
Metronidazole (n = 8) | 5 | 87.5 | 12.25 |
Amoxicillin–clavulanic acid (n = 19) | 30 | 68.4 | 31.6 |
Amoxicillin (n = 6) | 10 | 66.6 | 33.3 |
Sulfamethoxazole/trimethoprim (n = 5) | 25 | 60 | 40 |
Marbofloxacin (n = 16) | 5 | 25 | 75 |
Enrofloxacin (n = 16) | 5 | 18.75 | 81.25 |
Azithromycin (n = 4) | 15 | 0 | 100 |
Ceftriaxone (n = 1) | 30 | 0 | 100 |
Erythromycin (n = 3) | 15 | 0 | 100 |
Gentamicin (n = 2) | 10 | 0 | 100 |